Seattle startup Lumen Bioscience to build algae manufacturing plant in former bakery Seattle-based biotech company Lumen Bioscience, which manufactures proteins in algae, will expand its manufacturing operations to a former bakery in… Read More
Migraine drugmaker Alder Biopharmaceuticals to be acquired for nearly $2B by Lundbeck Danish drugmaker Lundbeck is set to buy Bothell, Wash.-based Alder Biopharmaceuticals in a deal that could be worth up to… Read More
Seattle Genetics shares rise on strong Adcetris sales, $218M in revenue for Q2 Cancer drugmaker Seattle Genetics reported stronger-than-expected revenues for the second quarter as its stock rose more than 8 percent in… Read More
